Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Clinical trial NCT02868242 · COMPLETED
Trial details
- NCT number
- NCT02868242
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-28
- Primary completion
- 2018-11-12
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.